The highest number of PRIMPOL deficient tumours was observed in breast cancer patients diagnosed with invasive breast cancer (1.7%; 14 out of 817), consisting of invasive lobular carcinoma or invasive ductal carcinoma, or a mixed group (42). This evidence concerns the gene PRIMPOL and invasive breast carcinoma.